Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · November 07, 2021

Cardiorenal Protection With SGLT2 Inhibitors in Diabetes Mellitus

Metabolism

 

Additional Info

Metabolism
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease
Metab. Clin. Exp. 2021 Oct 23;[EPub Ahead of Print], H Liu, VS Sridhar, J Boulet, A Dharia, A Khan, PR Lawler, D Cherney

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading